{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-012724","form_type":"8-K","ticker":"PETV","cik":"0001512922","company_name":"PetVivo Holdings, Inc.","filed_at":"2023-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.176536+00:00","generated_at":"2026-06-17T00:41:45.758999+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PetVivo raises $2.15M via registered direct offering of 782,675 shares at $2.75","bullets":["Gross proceeds of $2,152,355 from sale of 782,675 shares at $2.75/share.","Net proceeds ~$2.06M after $25,000 expenses and $63,456 finder fee to Bancroft Capital.","Funds to be used for commercialization of Spryng™, clinical trials, and working capital.","Bancroft Capital introduced investors purchasing 461,500 shares ($1.27M), earning 5% fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-012724","json":"https://secwatch.observer/filing/0001493152-23-012724.json","markdown":"https://secwatch.observer/filing/0001493152-23-012724.md","text":"https://secwatch.observer/filing/0001493152-23-012724.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223012724/0001493152-23-012724-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223012724/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T00:41:45.758999+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"239c792c0b93ad3460b81e87608a9230816f29e0","claim":"PetVivo Holdings, Inc. entered into Finders Fee Agreement with Bancroft Capital, LLC valued at $63,456.25 (effective 2023-03-28).","evidence_excerpt":"The Company engaged Bancroft, a broker-dealer registered with the SEC and a member of FINRA, pursuant to a finder’s agreement dated March 28, 2023 (“Finders Fee Agreement”) to introduce it to investors.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223012724/0001493152-23-012724-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Bancroft Capital, LLC"},{"label":"Value","value":"$63,456.25"},{"label":"Effective","value":"2023-03-28"}],"fact_type":"material_agreement"},{"claim_id":"609863b9929ca1772fa3359692038f9ca32fd6ec","claim":"PetVivo Holdings, Inc. entered into Purchase Agreement with certain investors valued at $2,152,355 (effective 2023-04-17).","evidence_excerpt":"PetVivo Holdings, Inc. (the “Company”) entered into certain documents, including a securities purchase agreement dated April 17, 2023 and/or other confirmation of purchase (the “Purchase Agreement”), with certain investors","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1512922/000149315223012724/0001493152-23-012724-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors"},{"label":"Value","value":"$2,152,355"},{"label":"Effective","value":"2023-04-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}